Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Learn more
OK
Skip to main content (Press Enter).
Sign In
Skip auxiliary navigation (Press Enter).
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
Search Options
About
What is the AMS
AMS International Scientific Committee
AMS Educational Executive Committee
AMS Ambassadors
Certifications and Educational Credits
Upcoming Events
Videos & Webinars
International Events
Become a Speaker
Videos On Demand
Education 365
Features
AMS Features
Blogs
Industry
Industry Partners
Become a Sponsor
Features
Blogs
Blog Viewer
Blogs
United States systemic psoriasis treatments: increases in the use of biologic agents and plateau of methotrexate and oral small molecule inhibitors
By
- AMS
posted
Feb 20, 2020 11:39 AM
0
Recommend
.
0 comments
0 views
Permalink
Related Content
Emerging systemic therapies for atopic dermatitis: oral small molecules and targeted topical agents
- AMS
Added Nov 04, 2020
Blog Entry
Systemic treatment of psoriasis and psoriatic arthritis in the United States: a cross-sectional study
- AMS
Added Jul 27, 2020
Blog Entry
Comparison of psoriasis guidelines for use of IL-23 inhibitors in the United States and United Kingdom: a critical appraisal and comprehensive review
- AMS
Added Sep 25, 2020
Blog Entry
New evidence-based resources to guide treatment of plaque psoriasis
- AMS
Added Sep 08, 2021
Blog Entry
Language proficiency and biologics access: a population study of psoriasis patients in the United States
- AMS
Added Sep 15, 2020
Blog Entry
© 2022 AMS, Aesthetic Multispecialty Society. All Rights Reserved.
Powered by Higher Logic